N. Turan Et Al. , "The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Turan, N. Et Al. 2011. The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .
Turan, N., Koca, D., Dane, F., Ozdemir, N., Ustaalioglu, B. B. O., Oztop, I., ... Ulas, A.(2011). The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
Turan, N. Et Al. "The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Turan, N. Et Al. "The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Turan, N. Et Al. (2011) . "The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
@article{article, author={N. Turan Et Al. }, title={The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}